These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
57 related articles for article (PubMed ID: 22472562)
1. Eating, Sleep, and Social Patterns as Independent Predictors of Clinical, Metabolic, and Biochemical Behaviors Among Elite Male Athletes: The EROS-PREDICTORS Study. Cadegiani FA; Kater CE Front Endocrinol (Lausanne); 2020; 11():414. PubMed ID: 32670198 [No Abstract] [Full Text] [Related]
2. Sitagliptin Decreases Visceral Fat and Blood Glucose in Women With Polycystic Ovarian Syndrome. Devin JK; Nian H; Celedonio JE; Wright P; Brown NJ J Clin Endocrinol Metab; 2020 Jan; 105(1):136-51. PubMed ID: 31529097 [TBL] [Abstract][Full Text] [Related]
3. Effect of oral glucose administration on rebound growth hormone release in normal and obese women: the role of adiposity, insulin sensitivity and ghrelin. Pena-Bello L; Pertega-Diaz S; Outeiriño-Blanco E; Garcia-Buela J; Tovar S; Sangiao-Alvarellos S; Dieguez C; Cordido F PLoS One; 2015; 10(3):e0121087. PubMed ID: 25782001 [TBL] [Abstract][Full Text] [Related]
7. Pre- versus postmenopausal age, estradiol, and peptide-secretagogue type determine pulsatile growth hormone secretion in healthy women: studies using submaximal agonist drive and an estrogen clamp. Hudson SB; Schroeder DR; Bailey JN; Mielke KL; Erickson D; Miles JM; Bowers CY; Veldhuis JD J Clin Endocrinol Metab; 2010 Jan; 95(1):353-60. PubMed ID: 19858315 [TBL] [Abstract][Full Text] [Related]
8. Multipathway modulation of exercise and glucose stress effects upon GH secretion in healthy men. Veldhuis JD; Olson TP; Takahashi PY; Miles JM; Joyner MJ; Yang RJ; Wigham J Metabolism; 2015 Sep; 64(9):1022-30. PubMed ID: 26028283 [TBL] [Abstract][Full Text] [Related]
9. Determinants of GH-releasing hormone and GH-releasing peptide synergy in men. Veldhuis JD; Bowers CY Am J Physiol Endocrinol Metab; 2009 May; 296(5):E1085-92. PubMed ID: 19240251 [TBL] [Abstract][Full Text] [Related]
10. Lowering total plasma insulin-like growth factor I concentrations by way of a novel, potent, and selective growth hormone (GH) receptor antagonist, pegvisomant (B2036-peg), augments the amplitude of GH secretory bursts and elevates basal/nonpulsatile GH release in healthy women and men. Veldhuis JD; Bidlingmaier M; Anderson SM; Wu Z; Strasburger CJ J Clin Endocrinol Metab; 2001 Jul; 86(7):3304-10. PubMed ID: 11443205 [TBL] [Abstract][Full Text] [Related]